[The effect of a new calcium antagonist (Ro 11-1781) in supraventricular paroxysmal tachycardia].
D000293:Adolescent; D000328:Adult; D002986:Clinical Trials as Topic; D004558:Electric Stimulation; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate; D006571:Heterocyclic Compounds / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010647:Phenyl Ethers / Q000627:therapeutic use*; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy* / Q000503:physiopathology / Q000628:therapy
D006571:Heterocyclic Compounds; D010647:Phenyl Ethers
Die Wirkung eines neuen Kalzium-antagonisten (Ro 11-1781) bei supraventrikulären paroxysmalen Tachykardien.